Intended for healthcare professionals

Letters

Screening for hereditary haemochromatosis should be implemented now

BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7228.183 (Published 15 January 2000) Cite this as: BMJ 2000;320:183
  1. Katrina Allen (allenk@cryptic.rch.unimelb.edu.au), paediatric gastroenterologist,
  2. Robert Williamson, director
  1. Murdoch Institute, Royal Children's Hospital, Parkville, 3052, Victoria, Australia

    EDITOR—The editorial by Haddow and Bradley on population screening for haemochromatosis concludes that now is too early to start population screening because of uncertainties about the proportion of homozygotes who will express symptoms of the disease.1 Haemochromatosis has been recognised as a clinical entity for over 150 years, but the gene that is mutated was not identified until 1996. Clinical haemochromatosis, defined by the presence of abnormal serum iron variables, has consistently been estimated to affect …

    View Full Text

    Log in

    Log in through your institution

    Subscribe

    * For online subscription